VICTORY CAPITAL MANAGEMENT INC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 148 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$16,288,422
+5.3%
689,603
-33.5%
0.02%
-5.6%
Q3 2023$15,468,126
+2797.7%
1,037,433
+2028.1%
0.02%
+1700.0%
Q2 2023$533,813
+507.5%
48,750
+383.8%
0.00%
Q1 2023$87,871
-43.3%
10,077
-76.3%
0.00%
Q3 2021$155,000
-16.2%
42,4480.0%0.00%
Q2 2021$185,000
-42.2%
42,448
-39.7%
0.00%
Q1 2021$320,000
-23.8%
70,442
-3.8%
0.00%
Q4 2020$420,000
+14.8%
73,215
+44.8%
0.00%
Q3 2020$366,000
+44.1%
50,554
-30.6%
0.00%
Q2 2020$254,000
+17.6%
72,812
-50.0%
0.00%
Q1 2020$216,000
+43.0%
145,624
+89.2%
0.00%
Q4 2019$151,000
-61.7%
76,9780.0%0.00%
-100.0%
Q3 2019$394,000
+4277.8%
76,978
+5923.3%
0.00%
Q2 2019$9,000
-47.1%
1,2780.0%0.00%
Q1 2019$17,000
+70.0%
1,2780.0%0.00%
Q4 2018$10,000
-41.2%
1,278
-16.0%
0.00%
Q3 2018$17,000
-5.6%
1,522
+15.1%
0.00%
Q2 2018$18,0001,3220.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$11,887,0008.85%
Foresite Capital Management IV, LLC 1,787,094$12,939,0002.92%
Copernicus Capital Management, LLC 278,416$2,016,0001.92%
Sio Capital Management, LLC 1,159,236$8,393,0001.66%
ACUTA CAPITAL PARTNERS, LLC 765,000$5,539,0001.50%
Avoro Capital Advisors LLC 10,300,000$74,572,0001.06%
Boxer Capital, LLC 4,000,000$28,960,0001.00%
Vivo Capital, LLC 2,089,356$15,127,0000.87%
EAM Global Investors LLC 284,534$2,060,0000.76%
Versant Venture Management, LLC 543,753$3,937,0000.72%
View complete list of CYMABAY THERAPEUTICS INC shareholders